The use of biocompounds as agents with potential anti-obesity effects might be a feasible alternative to the prescription of traditional drugs in the near future. The goal of the present study was to screen five different compounds in relation to their ability to prevent body weight gain and ameliorate obesity-associated metabolic impairments, namely insulin resistance. For this purpose, seventy Wistar rats were randomly assigned into seven experimental groups. A standard diet-fed control group (control, n=10); a high-fat, high-sucrose diet-fed group (HFS, n=10) and five experimental groups which were fed the HFS diet supplemented with one of the following biocompounds; curcumin (100 mg/kg bw, n=10), chlorogenic acid (50 mg/kg bw, n=10), coumaric acid (100 mg/kg bw, n=10), naringin (100 mg/kg bw, n=10) and leucine (1 % of diet, n=10). These results confirm the effectiveness of all the compounds to reduce significantly food efficiency, despite the significant higher food intake. Moreover, visceral fat mass percentage was significantly decreased after naringin and coumaric acid supplementation. In fact, this finding might be related to the considerable amelioration of HOMA-IR index detected in naringin-treated animals. A significant reduction in serum insulin levels and an improvement in the intraperitoneal glucose tolerance test and AUC were found in leucine-and coumaric acid-treated rats, respectively. In summary, the tested biocompounds, particularly naringin, coumaric acid and leucine, showed potential benefits in the prevention of obesity-related complications in rats, at least at the proved doses.
Obesity has been defined as the pandemic of the 21 st century by the World Health Organization [1] . Obesity is a health problem itself, but it is also associated with numerous metabolic complications [2] , resulting in a public health burden that implies high socio-economic costs [3] . Even if obesity is considered a preventable disease, greatly influenced by diet and exercise [4] , still, limited effective conventional medical treatments have been developed [5] . In this context, a growing interest has been focused on the development of natural products with clinical effectiveness, but lower side effects than the current anti-obesity drugs [6] .
In the recent decades, the use of phenolic phytochemicals or natural extracts for the management of obesity and other related diseases has been a scientific focus [7, 8] . In this sense, polyphenols such as flavanones (naringin), simple phenolic acids (coumaric acid and chlorogenic acid), curcuminoids (curcumin) [9] , and other biocompounds, as for instance leucine, a branched-chain amino acid [10] , have been suggested to exert potential health beneficial effects in the context of obesity. Indeed, knowledge of the impact of these types of compounds on the organism is being further unravelled through novel approaches such as the omics techniques [11] . The aim of this study was to evaluate the anti-obesity effects exerted by five biocompounds (naringin, curcumin, chlorogenic acid, coumaric acid and leucine) in a high-fat sucrose (HFS) diet-fed animal model generally used to mimic overweight and insulin resistance status of Westernized societies [12] . 
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Rats supplemented with the biocompounds (curcumin, coumaric acid, naringin and leucine) showed lower food efficiency than the non-treated HFS rats:
Final body-weight gain, which was significantly increased (165%, p< 0.001) after the HFS diet treatment (Figure 1 ), was slightly reduced at the end of the study in the animals supplemented with naringin and leucine ( Figure 1 ). Moreover, naringin and leucine significantly reduced body-weight gain at day 28 of the intervention period when compared with the HFS diet-fed control rats ( Figure 1 ). Despite the fact that significantly greater food intake was observed in all supplemented groups (Table 1) when compared with the HFS control rats, food efficiency was significantly lowered in all the groups supplemented with biocompounds, except in rats consuming chlorogenic acid ( Figure 2 ). These data suggest that the bioactive compounds impacted on the utilization of the food provided, as the animals gained less body-weight per ingested calories. Our data might agree with results obtained by Zhang et al. [10] , who stated that high-fat diet (HFD) fed obese mice were highly fuel efficient, which implied a greater body-weight gain per unit of calories consumed compared with the chow diet-fed mice. In contrast, HFD fed animals supplemented with leucine showed higher resting energy expenditure with lower fuel efficiency [10] .
In relation to the action of the biocompounds tested in the present study, although no data regarding animals' energy expenditure is available, it might be suggested that the treatment period with either curcumin, chlorogenic acid, coumaric acid, naringin and leucine, might have impacted on the animals' metabolism, inducing higher resting energy expenditure, higher capacity to burn food via dietinduced thermogenesis and/or inducing a greater capacity for fat oxidation [13] .
Naringin and coumaric acid reduced the adiposity levels induced by a HFS diet: HFS diet-fed animals evidenced a significant enlargement in total body fat and visceral adipose tissue compared with the control rats ( Figure 3 ). In contrast, coumaric acid produced a statistically significant reduction in visceral adipose tissue, while rats supplemented with naringin showed a statistically significant decrease in both visceral and total adipose tissue depots after a 37 days treatment period ( Figure 3 ). However, no significant differences were achieved in other organ weights (liver, spleen and gastrocnemius), neither in the mentioned groups nor in the rest of the supplemented groups (Table 1) . Protective effects of naringin on fat deposition might confirm the already proposed mechanism of action dependent on the activation of AMP kinase, leading to a suppression of lipid synthesis and inhibition of insulin resistance [14] . The prevention of adipose tissue accumulation exerted by the intake of coumaric acid was also reported in a model of HFD-fed Wistar rats. In this study, the anti-obesity effects of this compound were accompanied by a decrease in dyslipidaemia, hepatic steatosis, and oxidative stress [15] . Indeed, this research previously demonstrated in vitro the potential of coumaric acid to inhibit intracellular triglycerides and glycerol-3-phosphate dehydrogenase (GPDH) in 3T3-L1 adipocytes [16] . Furthermore, the role of coumaric acid was described to inhibit the expression of peroxisome proliferator-activated receptor gamma (PPARγ), involved in the regulation of insulin sensitivity and glucose homeostasis [17] and CCAT enhancer binding protein alpha (C/EBPα) protein levels, concluding the adipogenesis suppressive effect of these compounds.
Naringin and leucine showed insulin sensitizing effects, while coumaric acid tended to improve impaired glucose tolerance:
Impaired glucose tolerance is one of the major characteristics of insulin resistance [18] and the homeostasis model assessment of insulin resistance (HOMA-IR) index is usually used to assess the insulin resistance status. In our study, a significant reduction of HOMA-IR was found following naringin supplementation ( Figure  4A ) when compared with the HFS diet-fed obese rats, restating the beneficial effects of this flavonoid preventing the development of insulin resistance. Concomitantly, our data demonstrated that serum insulin levels were significantly lower in rats supplemented with leucine ( Figure 4B ). Leucine has been demonstrated to ameliorate glucose metabolism, in part due to a better insulin sensitivity resulting from a reduction in adiposity, while the induction of insulin secretion [19] has also been indicated as a possible mechanism responsible for the glycaemic control. Interestingly, in our study, even if leucine supplementation did not significantly reduce fat accumulation, this branched-chain amino acid was found to be effective in decreasing insulin levels, a feature that might be secondary to the improved insulin sensitivity, as suggested by Zhang et al. [10] . Furthermore, an intraperitoneal glucose tolerance test (IPGTT) was conducted to analyse the effects of biocompounds that showed the most promising effects concerning glucose metabolism. In this context, coumaric acid marginally decreased (p= 0.052) the area under the curve (AUC) and significantly reduced glucose levels 90 minutes after glucose administration ( Figures 5A and 5B) .
The present work highlights certain health beneficial effects derived from the intake of biocompounds in relation to obesity and obesityassociated metabolic disorders. Although individual outcomes produced by each bioactive compound might not be particularly remarkable, emphasis should be made in the fact that foods such as fruits and vegetables are complex mixtures of polyphenols, thus, consuming a dietary pattern rich in this sort of food may induce beneficial outcomes due to possible synergistic effects among the different compounds.
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Experimental
Biocompounds and diets:
Intraperitoneal glucose tolerance test: HFS, naringin, leucine and coumaric acid groups were selected to conduct an IPGTT during the 26 th and 27 th days of the total experimental period. After a 15-h fast, rats were injected intraperitoneally with glucose (2 g/kg bw in 30%, w/v, solution). Blood glucose levels were determined from the tail vein before (0') and after glucose injection (30', 60', 90', 150', 210') with a glucometer (Roche Diagnostics, Mannheim, Germany) and blood glucose test trips (Optium Plus, Abbott Diabetes Care, Witney Oxon, UK). The glucose content was expressed as mg/dL, and the AUC were determined by the trapezoidal rule approach [25] , as measured elsewhere [8] .
Serum measurements: Serum insulin (Mercodia AB, Uppsala, Sweden) was determined by enzyme-linked-immunosorbent assay (ELISA) using an automatized TRITURUS equipment (Grifols International S.A., Barcelona, Spain). Fasting glucose levels were measured using a glucometer (Roche Diagnostics) and blood glucose test trips (Optimum Plus, Abbott Diabetes Care). Insulin resistance was assessed by the HOMA-IR index formula [26] : [serum glucose levels (mmol/L) x insulin levels (mU/L)/ 22.5].
Statistical analysis:
All the results are expressed as mean + standard error of the mean (SEM). Statistical significance of differences among the groups was evaluated using Student's T-test. A level of probability of p< 0.05 was set as statistically significant.
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All analyses were performed using SPSS 15.0 packages of Windows (Chicago, IL).
